Inhibikase Therapeutics Inc (IKT)

Total Costs & Expenses

$21.05M

Quarterly · Period ending: · USD

IKT logo

IKT Total Costs & Expenses

Latest reported$21.05M
IKT Quarterly Total Costs & Expenses ($426.67K → $21.05M)
High-resolution chart · PNG

IKT total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
21,050,995
18,215,273
13,775,626
12,768,373
10,832,278
14,598,006
12,928,700
5,827,476
5,050,535
4,782,360
4,403,567
4,848,445
6,318,811
4,779,470
4,398,540
4,520,390
4,646,491
4,686,627
5,043,405
4,799,499
3,991,405
4,032,436
1,371,263
701,389
633,506
810,802
662,539
1,204,606
2,338,612
1,732,667
2,604,149
804,266
743,487
426,673
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.